109 related articles for article (PubMed ID: 19728850)
1. Clinical relevance of circulating midkine in ulcerative colitis.
Krzystek-Korpacka M; Neubauer K; Matusiewicz M
Clin Chem Lab Med; 2009; 47(9):1085-90. PubMed ID: 19728850
[TBL] [Abstract][Full Text] [Related]
2. Circulating midkine in Crohn's disease: clinical implications.
Krzystek-Korpacka M; Neubauer K; Matusiewicz M
Inflamm Bowel Dis; 2010 Feb; 16(2):208-15. PubMed ID: 19572374
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase-1 status in Crohn's disease and ulcerative colitis.
Boehm D; Krzystek-Korpacka M; Neubauer K; Matusiewicz M; Berdowska I; Zielinski B; Paradowski L; Gamian A
Inflamm Bowel Dis; 2009 Jan; 15(1):93-9. PubMed ID: 18626964
[TBL] [Abstract][Full Text] [Related]
4. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis.
Osada T; Ohkusa T; Okayasu I; Yoshida T; Hirai S; Beppu K; Shibuya T; Sakamoto N; Kobayashi O; Nagahara A; Terai T; Watanabe S
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S262-7. PubMed ID: 19120909
[TBL] [Abstract][Full Text] [Related]
5. Circulating midkine in malignant and non-malignant colorectal diseases.
Krzystek-Korpacka M; Diakowska D; Neubauer K; Gamian A
Cytokine; 2013 Oct; 64(1):158-64. PubMed ID: 23899719
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis.
Turner D; Mack DR; Hyams J; LeLeiko N; Otley A; Markowitz J; Kasirer Y; Muise A; Seow CH; Silverberg MS; Crandall W; Griffiths AM
J Crohns Colitis; 2011 Oct; 5(5):423-9. PubMed ID: 21939916
[TBL] [Abstract][Full Text] [Related]
7. Red cell distribution width for assessment of activity of inflammatory bowel disease.
Cakal B; Akoz AG; Ustundag Y; Yalinkilic M; Ulker A; Ankarali H
Dig Dis Sci; 2009 Apr; 54(4):842-7. PubMed ID: 18716874
[TBL] [Abstract][Full Text] [Related]
8. Enhanced formation of advanced oxidation protein products in IBD.
Krzystek-Korpacka M; Neubauer K; Berdowska I; Boehm D; Zielinski B; Petryszyn P; Terlecki G; Paradowski L; Gamian A
Inflamm Bowel Dis; 2008 Jun; 14(6):794-802. PubMed ID: 18213700
[TBL] [Abstract][Full Text] [Related]
9. [Significance of fecal lactoferrin in evaluation of disease activity in ulcerative colitis].
Xiang JY; Ouyang Q; Li GD
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2262-4. PubMed ID: 18001547
[TBL] [Abstract][Full Text] [Related]
10. Correlations of C-reactive protein levels and erythrocyte sedimentation rates with endoscopic activity indices in patients with ulcerative colitis.
Yoon JY; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
Dig Dis Sci; 2014 Apr; 59(4):829-37. PubMed ID: 24352705
[TBL] [Abstract][Full Text] [Related]
11. Correlations between the serum bilirubin level and ulcerative colitis: a case-control study.
Shi H; Feng Y; Jiang J; Zhao J; Li X; Liu X
Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):992-997. PubMed ID: 31205128
[TBL] [Abstract][Full Text] [Related]
12. Reduced Transferrin Levels in Active Inflammatory Bowel Disease.
Matusiewicz M; Neubauer K; Lewandowska P; Gamian A; Krzystek-Korpacka M
Biomed Res Int; 2017; 2017():9541370. PubMed ID: 29226154
[TBL] [Abstract][Full Text] [Related]
13. Peripheral Blood miR-148 Serves as a Novel Biomarker in Ulcerative Colitis Patients.
Ji Q; Li Y
Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538061
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-9: its interplay with angiogenic factors in inflammatory bowel diseases.
Matusiewicz M; Neubauer K; Mierzchala-Pasierb M; Gamian A; Krzystek-Korpacka M
Dis Markers; 2014; 2014():643645. PubMed ID: 24803722
[TBL] [Abstract][Full Text] [Related]
16. [Comparative usefulness of erythrocyte sedimentation rate and C-reactive protein in assessing the severity of ulcerative colitis].
Ha JS; Lee JS; Kim HJ; Moon TG; Chang DK; Lee JH; Kim YH; Rhee PL; Kim JJ; Rhee JC
Korean J Gastroenterol; 2006 Nov; 48(5):313-20. PubMed ID: 17132919
[TBL] [Abstract][Full Text] [Related]
17. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume.
Yüksel O; Helvaci K; Başar O; Köklü S; Caner S; Helvaci N; Abayli E; Altiparmak E
Platelets; 2009 Jun; 20(4):277-81. PubMed ID: 19459134
[TBL] [Abstract][Full Text] [Related]
18. Pancreatitis-associated protein has no additional value as a marker of disease activity in a real-life cohort of IBD patients.
Bodelier AG; Pierik MJ; van den Heuvel T; Bovee-Oudenhoven IM; de Boer E; Hameeteman W; Masclee AA; Jonkers D
Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):902-9. PubMed ID: 24915490
[TBL] [Abstract][Full Text] [Related]
19. Correlation of serum biomarkers with clinical severity and mucosal inflammation in Chinese ulcerative colitis patients.
Lok KH; Ng CH; Hung HG; Li KF; Li KK; Szeto ML
J Dig Dis; 2008 Nov; 9(4):219-24. PubMed ID: 18959594
[TBL] [Abstract][Full Text] [Related]
20. Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis.
Masoodi I; Kochhar R; Dutta U; Vaishnavi C; Prasad KK; Vaiphei K; Kaur S; Singh K
J Gastroenterol Hepatol; 2009 Nov; 24(11):1768-74. PubMed ID: 20136960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
